Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Platform for T lymphocyte genome engineering and in vivo high-throughput screening thereof

Platform for T lymphocyte genome engineering and in vivo high-throughput screening thereof

US Patent 11926839 · Granted Mar 12, 2024

Estimated economic value: $386,458,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for identification of membrane targets for enhancement of T cell ac2025
Compositions for identification of membrane targets for enhancement of T cell ac2025
CRISPR mediated in vivo modeling and genetic screening of tumor growth and metas2024
Delivery, use and therapeutic applications of the CRISPR-Cas systems and composi2021